News
-
-
PRESS RELEASE
mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics
mbiomics announces successful third closing of Series A funding round, raising €30 million to advance microbiome therapeutics, focusing on clinical evaluation of lead candidate MBX-116 for advanced melanoma